ClinicalTrials.Veeva

Menu

Triton Reference Database

Topcon logo

Topcon

Status

Completed

Conditions

Healthy Eyes

Treatments

Device: Topcon DRI OCT Triton (plus)

Study type

Observational

Funder types

Industry

Identifiers

NCT03067675
Triton RDB

Details and patient eligibility

About

The objective of this study is to collect OCT measurement data on normal healthy eyes.

Full description

The objective of this study is to collect OCT measurement data on normal healthy eyes in order to determine the reference limits for Topcon DRI OCT Triton based on the percentile points for 1%, 5%, 95%, and 99%.

Enrollment

500 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  1. Subjects 18 years of age or older on the date of informed consent
  2. Subjects able to understand the written informed consent and willing to participate as evidenced by signing the informed consent
  3. Subjects presenting at the site with normal eyes bilaterally (cataracts are acceptable)
  4. IOP ≤ 21 mmHg bilaterally
  5. BCVA 20/40 or better bilaterally

Exclusion Criteria

  1. Subjects unable to tolerate ophthalmic imaging

  2. Subjects with ocular media not sufficiently clear to obtain acceptable OCT images

  3. HFA visual field (24-2 Sita Standard, white on white) result unreliable (based on manufacturer's recommendation), defined as fixation losses > 20% or false positives > 33%, or false negatives > 33%

  4. Visual field defects consistent with glaucomatous optic nerve damage based on at least one of the following two findings:

    1. On pattern deviation (PD), there exists a cluster of 3 or more points in an expected location of the visual field depressed below the 5% level, at least 1 of which is depressed below the 1% level;
    2. Glaucoma hemi-field test "outside normal limits."
  5. Narrow angle

  6. History of leukemia, dementia or multiple sclerosis

  7. Concomitant use of hydroxychloroquine and chloroquine

Trial design

500 participants in 1 patient group

Subjects Presenting With Normal Eyes
Description:
Subjects with no known ocular diseases will be scanned on the Topcon DRI OCT Triton (plus) device
Treatment:
Device: Topcon DRI OCT Triton (plus)

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems